Skip to main content
All lobbying filings

THE NEW ENGLAND COUNCIL

Lobbying for NEW ENGLAND COUNCIL

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $10,000.00 expenses · posted Jan 15, 2026

Official filing document

 Bills named in this filing 4
  • HR 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • S 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
  • HR 2441
    Improving Disclosure for Investors Act of 2025
  • HR 3383
    Employee Equity Investment Act of 2023
 Lobbying activity 4
Health Issues

H.R. 5343/S. 1717 - Ensuring Patient Access to Critical Breakthroughs Act

Trade (domestic/foreign)

Support for United States Mexico Canada Agreement (USMCA)

Financial Institutions/Investments/Securities

H.R. 3383 - INVEST Act H.R. 2441 - Improving Disclosure for Investors Act

Housing

Changes to U.S. Department of Housing & Urban Development Continuum of Care Program

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem